Exchange: NYSEMkt·Updated 04:18 AM EST

About PLX

About

Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
226

Frequently Asked Questions

Advertisement|Remove ads.